Skip to main content

PaCO2 is nonlinearly associated with NIV failure in patients with hypoxemic respiratory failure

Abstract

Objective

To explore the association between PaCO2 and noninvasive ventilation (NIV) failure in patients with hypoxemic respiratory failure.

Methods

A retrospective study was performed in a respiratory ICU of a teaching hospital. Patients admitted to ICU between 2011 and 2019 were screened. We enrolled the patients with hypoxemic respiratory failure. However, patients who used NIV due to acute-on-chronic respiratory failure or heart failure were excluded. Data before the use of NIV were collected. Requirement of intubation was defined as NIV failure.

Results

A total of 1029 patients were enrolled in final analysis. The rate of NIV failure was 45% (461/1029). A nonlinear relationship between PaCO2 and NIV failure was found by restricted cubic splines (p = 0.03). The inflection point was 32 mmHg. The rate of NIV failure was 42% (224/535) in patients with PaCO2 >32 mmHg. However, it increased to 48% (237/494) in those with PaCO2 ≤ 32 mmHg. The crude and adjusted hazard ratio (HR) for NIV failure was 1.36 (95%CI:1.13–1.64) and 1.23(1.01–1.49), respectively, if the patients with PaCO2 >32 mmHg were set as reference. In patients with PaCO2 ≤ 32 mmHg, one unit increment of PaCO2 was associated with 5% reduction of NIV failure. However, it did not associate with NIV failure in patients with PaCO2 >32 mmHg.

Conclusions

PaCO2 and NIV failure was nonlinear relationship. The inflection point was 32 mmHg. Below the inflection point, lower PaCO2 was associated with higher NIV failure. However, it did not associate with NIV failure above this point.

Peer Review reports

Introduction

Noninvasive ventilation (NIV) is one of the main oxygen strategies for patients with acute hypoxemic respiratory failure. It can reduce respiratory rate, diminish the swing of esophageal pressure, and improve the oxygenation [1]. However, the rate of NIV failure is high in patients with hypoxemic respiratory failure. It ranges from 40 to 57% [2,3,4]. And patients with NIV failure are more likely to die in intensive care units (ICUs) [4]. Identification of the patients who are suitable for NIV is important.

In patients with de novo acute respiratory failure who required intubation for invasive mechanical ventilation, the time from NIV initiation to intubation was 78 ± 65 h in non-survivors versus 32 ± 24 h in survivors [5]. It indicates that delayed intubation may be associated with increased mortality. Another study also reported that pre-intubation NIV duration was associated with increased 30-day mortality [6]. Therefore, early identification of the patients who required invasive mechanical ventilation and early application of intubation is a promising strategy to reduce mortality. However, how to identify the patients at high risk for NIV failure is challenging. In current study, we aimed to explore the association between PaCO2 and NIV failure in patients with acute hypoxemic respiratory failure and determine the cutoff value to predict NIV failure.

Methods

This was a retrospective study performed in a respiratory ICU of a teaching hospital. The study protocol was approved by the ethics committee of the First Affiliated Hospital of Chongqing Medical University (No. K2024-061-01). As the retrospective design, the informed consent was waived. Patients who admitted to our ICU between 2011 and 2019 were screened. The inclusion criteria were hypoxemia, use of NIV as a first-line therapy, and PaCO2 ≤ 45 mmHg before the use of NIV [7, 8]. The exclusion criteria were PaCO2 >45 mmHg before the use of NIV, heart failure as the primary reason for NIV, and presence of acute-on-chronic respiratory failure. And those patients with missing data were also excluded. In addition, some patients received high-flow nasal cannula (HFNC) after 2017. The use of NIV or HFNC was determined by the attending physicians based on their experience and the availability of the device.

Patients admitted to our ICU were managed following hospital protocols [9]. In our department, the dedicated noninvasive ventilator was used for all patients. The indications for NIV were as follows: (1) tachypnea (respiratory rate > 25 breaths/min), (2) clinical presentation of respiratory distress at rest (such as active contraction of the accessory inspiratory muscles or paradoxical abdominal motion), or (3) PaO2 < 60 mmHg at room air or PaO2/FiO2 < 300 mmHg with supplemental oxygen. If supplemental oxygen was used, FiO2 was estimated as follows: FiO2 (%) = 21 + 4×fow (L/min) [10, 11]. The contraindications for NIV were as follows: (1) facial or nasal abnormalities, (2) recent gastric or esophageal surgery, (3) active upper gastrointestinal bleeding, (4) high risk for aspiration, (5) unable to clear sputum, (6) hemodynamic instability without response to fluids or vasoactive agents, and (7) lack of cooperation [12]. However, the use of NIV was at the physician’s discretion.

NIV was managed by attending physicians, respiratory therapists, and nurses. A face mask was the main interface for NIV treatment. A nasal mask was the secondary choice if the patient failed to tolerate the face mask. Selection of the mask was based on the patient’s facial or nasal type. The straps of the mask were kept as tight as possible while remaining comfortable to the patient. Inspiratory pressure was initially set at 8 or 10 cmH2O and then increased in increments of 2 cmH2O to achieve the best control of dyspnea. Expiratory pressure was initially set at 4 cmH2O and then increased to maintain the patency of the alveoli. It was gradually increased until the SpO2 or PaO2 reached a plateau. However, it also balanced patient’s tolerance. Usually the expiratory pressure was kept between 4 and 10 cmH2O. FiO2 was set to achieve peripheral oxygen saturation greater than 92%. If the respiratory conditions were gradually improved, the liberation from NIV was performed. However, intubation was performed if the respiratory conditions were progressively deteriorated.

We collected the age, gender, diagnosis, and disease severity from the medical records. Disease severity was assessed by APACHE II score. The heart rate, respiratory rate, systolic blood pressure, diastolic blood pressure, pH, PaCO2, and PaO2/FiO2 were also extracted from the medical records. NIV failure and hospital mortality were also recorded.

The Statistical Product and Service Solutions (version 25.0) and R (version 4.3.2) were used to analyze the data. Continuous variables were presented using the mean and standard deviation, whereas categorical variables were presented as percentages. A nonlinear relationship between PaCO2 and NIV failure was analyzed by restricted cubic splines. If a nonlinear relationship was found, a cutoff value was determined at the inflection point. Cox proportional hazards regression was used to explore the association between low PaCO2 and NIV failure. The hazard ratio (HR) for NIV failure was adjusted by confounders. Kaplan-Meier curves were also used to explore the cumulative incidence of NIV failure between two groups. A p value <0.05 suggests statistical significance.

Results

We screened 3009 patients in current study (Fig. 1). After exclusion of the ineligible patients, a total of 1029 patients were enrolled in final analysis. The mean age was 64 years (Table 1). The main diagnosis was pneumonia (accounting for 57%), and acute respiratory distress syndrome (ARDS) was the secondary diagnosis (accounting for 20%). Before the use of NIV, the mean respiratory rate was 33 breaths/min, mean PaCO2 was 33 mmHg, and mean PaO2/FiO2 was 156 mmHg. Four hundred and sixty-one patients (45%) experienced NIV failure and 338 patients (33%) died in hospital.

Fig. 1
figure 1

Patient screening

Table 1 Demographics

A nonlinear relationship between PaCO2 and NIV failure was identified by restricted cubic splines (p = 0.03). The inflection point was 32 mmHg (Fig. 2). Four hundred and ninety-four patients (48%) had PaCO2 ≤ 32 mmHg before the use of NIV (Table 1). Patients with PaCO2 ≤ 32 mmHg had higher APACHE II score, higher respiratory rate, higher heart rate, and lower oxygenation than those with PaCO2 >32 mmHg.

Fig. 2
figure 2

Relationship between PaCO2 and NIV failure

The rate of NIV failure was 48% in patients with PaCO2 ≤ 32 mmHg versus 42% in those with PaCO2 >32 mmHg (p = 0.05). The crude HR for NIV failure was 1.36 (95%CI: 1.13–1.64) if the patients with PaCO2 >32 mmHg were set as reference (Table 2). When it was adjusted by age, sex, diagnosis, APACHE II score, respiratory rate, heart rate, systolic blood pressure, diastolic blood pressure, pH and PaO2/FiO2, the HR was 1.23 (95%CI: 1.01–1.49). The cumulative incidence of NIV failure within 28 days was also much higher in patients with PaCO2 ≤ 32 mmHg (p = 0.01 for log-rank test, Fig. 3). After 1–2 h of NIV, the crude and adjusted HR for NIV failure was 1.28 (95%CI: 1.06–1.53) and 1.32 (1.08–1.60), respectively, if the PaCO2 was still less than 32 mmHg.

Table 2 HR (95% CIs) for NIV failure
Fig. 3
figure 3

The cumulative incidence of NIV failure in patients with PaCO2 more than and less than 32 mmHg

In patients with PaCO2 >32 mmHg, the adjusted HR for NIV failure was 0.97 (95%CI: 0.94–1.01, p = 0.16) per one unit increment of PaCO2, indicating no association between PaCO2 and NIV failure (Table 3). However, in patient with PaCO2 ≤ 32 mmHg, the adjusted HR for NIV failure was 0.95 (95%CI: 0.92–0.98, p < 0.01) per one unit increment of PaCO2. The rate of NIV failure was 65.7%, 55.9%, 46.6%, 39.3%, and 42.7% in patients with PaCO2 less than 20 mmHg, 20.1–25 mmHg, 25.1–30 mmHg, 30.1–35 mmHg, and 35.1–45 mmHg, respectively (p < 0.01 between groups, Fig. 4).

Table 3 HR (95% CIs) for NIV failure in different subgroups
Fig. 4
figure 4

The rate of NIV failure in patients with different subgroups classified by PaCO2

Discussion

This study showed that the relationship between PaCO2 and NIV failure was nonlinear in patients with hypoxemic respiratory failure. The inflection point was 32 mmHg. When the PaCO2 was less than 32 mmHg, lower PaCO2 was associated with higher NIV failure. However, there is no association between PaCO2 and NIV failure if the PaCO2 more than 32 mmHg in patients with hypoxemic respiratory failure.

To the best of our knowledge, this is the first study to explore the relationship between PaCO2 and NIV failure in patients with hypoxemic respiratory failure. Previous studies have shown that many variables were associated with NIV failure such as respiratory rate, pH, PaO2/FiO2, disease severity, and so on [13,14,15]. Our study demonstrated that PaCO2 ≤ 32 mmHg was association with increased NIV failure. This variable can be served as another predictor to predict NIV failure in patients with hypoxemic respiratory failure. Use of NIV in patients with low PaCO2 should be cautious and frequent assessment of the efficacy of NIV is required to avoid delayed intubation.

PaCO2 reflects the ventilation status. Low PaCO2 is associated with excess ventilation. A previous study reported by Carteaux and colleagues shown that patients with high minute ventilation or high tidal volume were more likely to experience NIV failure [8]. In that study, the ICU ventilator with double circuits was used to deliver gas to the patient. And the expired tidal volume was recorded. However, we only used dedicated noninvasive ventilators with single circuit to deliver gas. The expired tidal volume is unavailable. These ventilators only calculated the estimated tidal volume. The accuracy of tidal volume was based on the algorithms of each ventilator. It was also influenced by air leak around the mask. Since the tidal volume estimated by dedicated noninvasive ventilator is not accurate, use of PaCO2 as a predictor to predict NIV failure is complementary to tidal volume.

PaCO2 can partly reflect the respiratory drive. High respiratory drive leads to strong muscle contraction and large negative pleural swings, which leads to lung injury [16,17,18]. As preservation of spontaneous breathing is required for NIV, it is named as self-inflicted lung injury [19]. Exposure to high respiratory drive is associated with increased severity of lung injury. This may be another reason for the association between low PaCO2 and high rate of NIV failure.

Our study has several limitations. Firstly, the use of NIV was at the physician’s discretion. This may delay the timing of intubation. Secondly, we only demonstrated that patients with PaCO2 less than 32 mmHg were associated with increased NIV failure. This did not mean that NIV should not be used in these patients. A randomized controlled trial is encouraged to determine this issue. Thirdly, use of HFNC may influence patient allocation. However, only a small number of HFNC devices were introduced to our department at the end stage of the study period. Use of HFNC was at physician’s discretion and the availability of the device. Therefore, the selection bias using NIV or HFNC is small.

Conclusion

Nonlinear relationship between PaCO2 and NIV failure was found in patients with hypoxemic respiratory failure. When the PaCO2 was less than 32 mmHg, lower PaCO2 was associated with higher NIV failure. However, there was no association between PaCO2 and NIV failure if the PaCO2 was more than 32 mmHg in patients with hypoxemic respiratory failure.

Data availability

The dataset used and/or analyzed during the current study is available from the corresponding author on reasonable request.

Abbreviations

ICU:

intensive care unit

ARDS:

acute respiratory distress syndrome

NIV:

noninvasive ventilation

HR:

hazard ratio

CI:

confidence interval

HFNC:

high-flow nasal cannula

References

  1. L’Her E, Deye N, Lellouche F, et al. Physiologic effects of noninvasive ventilation during acute lung injury. Am J Respir Crit Care Med. 2005;172:1112–8.

    Article  PubMed  Google Scholar 

  2. Tonelli R, Fantini R, Tabbì L, et al. Early Inspiratory Effort Assessment by Esophageal Manometry predicts noninvasive ventilation outcome in De Novo Respiratory failure. A pilot study. Am J Respir Crit Care Med. 2020;202:558–67.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Wang J, Duan J, Zhou L. Incidence of noninvasive ventilation failure and mortality in patients with acute respiratory distress syndrome: a systematic review and proportion meta-analysis. BMC Pulm Med. 2024;24:48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Rodríguez A, Ferri C, Martin-Loeches I, et al. Risk factors for noninvasive ventilation failure in critically ill subjects with confirmed influenza infection. Respir Care. 2017;62:1307–15.

    Article  PubMed  Google Scholar 

  5. Carrillo A, Gonzalez-Diaz G, Ferrer M, et al. Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure. Intensive Care Med. 2012;38:458–66.

    Article  PubMed  Google Scholar 

  6. Polok K, Fronczek J, Artigas A, et al. Noninvasive ventilation in COVID-19 patients aged ≥ 70 years-a prospective multicentre cohort study. Crit Care. 2022;26:224.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Thille AW, Contou D, Fragnoli C, et al. Non-invasive ventilation for acute hypoxemic respiratory failure: intubation rate and risk factors. Crit Care. 2013;17:R269.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Carteaux G, Millán-Guilarte T, De Prost N, et al. Failure of noninvasive ventilation for De Novo Acute Hypoxemic Respiratory failure: role of tidal volume. Crit Care Med. 2016;44:282–90.

    Article  PubMed  Google Scholar 

  9. Duan J, Chen L, Liu X, et al. An updated HACOR score for predicting the failure of noninvasive ventilation: a multicenter prospective observational study. Crit Care. 2022;26:196.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Branson RD, Hess DR, Chatbum RL. Respiratory care equipment. Philadelphia: J.B. Lippincott Company; 1995. pp. 55–62.

    Google Scholar 

  11. Wang K, Zhao W, Li J, et al. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China. Ann Intensive Care. 2020;10:37.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Duan J, Tang X, Huang S, et al. Protocol-directed versus physician-directed weaning from noninvasive ventilation: the impact in chronic obstructive pulmonary disease patients. J Trauma Acute Care Surg. 2012;72:1271–5.

    Article  PubMed  Google Scholar 

  13. Yoshida Y, Takeda S, Akada S, et al. Factors predicting successful noninvasive ventilation in acute lung injury. J Anesth. 2008;22:201–6.

    Article  PubMed  Google Scholar 

  14. Antonelli M, Conti G, Moro ML, et al. Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med. 2001;27:1718–28.

    Article  CAS  PubMed  Google Scholar 

  15. Carron M, Freo U, Zorzi M, et al. Predictors of failure of noninvasive ventilation in patients with severe community-acquired pneumonia. J Crit Care. 2010;25:e540549–514.

    Article  Google Scholar 

  16. Cruces P, Retamal J, Hurtado DE, et al. A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection. Crit Care. 2020;24:494.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Battaglini D, Robba C, Ball L, et al. Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review. Br J Anaesth. 2021;127:353–64.

    Article  CAS  PubMed  Google Scholar 

  18. Bachmann MC, Cruces P, Díaz F, et al. Spontaneous breathing promotes lung injury in an experimental model of alveolar collapse. Sci Rep. 2022;12:12648.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Pettenuzzo T, Sella N, Zarantonello F, et al. How to recognize patients at risk of self-inflicted lung injury. Expert Rev Respir Med. 2022;16:963–71.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

J.D. conceived the study and took responsibility for the integrity of the study. X.X., M.M., Y.M., W.H., L.B., and J.D. joined in study design and manuscript preparation. X.X. joined in patient screening, data collection, data management, and data interpretation. All authors contributed to the intellectual content of the manuscript and approved the manuscript version submitted for publication.

Corresponding author

Correspondence to Jun Duan.

Ethics declarations

Ethical approval and consent to participate

The study protocol was approved by the ethics committee of the First Affiliated Hospital of Chongqing Medical University (No. K2024-061-01). Informed consent was waived due to the retrospective design. And current study was performed in accordance with the Declaration of Helsinki.

Consent for publication

Not applicable.

Competing interests

We declare that we have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, X., Ma, M., Min, Y. et al. PaCO2 is nonlinearly associated with NIV failure in patients with hypoxemic respiratory failure. BMC Pulm Med 24, 228 (2024). https://doi.org/10.1186/s12890-024-03023-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12890-024-03023-8

Keywords